Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 309

1.

Performance of an easy-to-use prediction model for renal patient survival: an external validation study using data from the ERA-EDTA Registry.

Hemke AC, Heemskerk MBA, van Diepen M, Kramer A, de Meester J, Heaf JG, Abad Diez JM, Torres Guinea M, Finne P, Brunet P, Vikse BE, Caskey FJ, Traynor JP, Massy ZA, Couchoud C, Groothoff JW, Nordio M, Jager KJ, Dekker FW, Hoitsma AJ.

Nephrol Dial Transplant. 2018 Jan 16. doi: 10.1093/ndt/gfx348. [Epub ahead of print]

PMID:
29346645
2.

Geographical Variations in Blood Pressure Level and Seasonality in Hemodialysis Patients.

Duranton F, Kramer A, Szwarc I, Bieber B, Gayrard N, Jover B, Vetromile F, Massy ZA, Combe C, Tentori F, Jager KJ, Servel MF, Argilés À.

Hypertension. 2018 Feb;71(2):289-296. doi: 10.1161/HYPERTENSIONAHA.117.10274. Epub 2017 Dec 18.

PMID:
29255071
3.

Kidney transplant outcomes from older deceased donors: a paired kidney analysis by the European Renal Association-European Dialysis and Transplant Association Registry.

Pippias M, Jager KJ, Caskey F, Casula A, Erlandsson H, Finne P, Heaf J, Heinze G, Hoitsma A, Kramar R, Lempinen M, Magaz A, Midtvedt K, Mumford LL, Pascual J, Prütz KG, Sørensen SS, Traynor JP, Massy ZA, Ravanan R, Stel VS.

Transpl Int. 2017 Dec 5. doi: 10.1111/tri.13103. [Epub ahead of print]

PMID:
29210108
4.

Lowering Expectations with Niacin Treatment for CKD-MBD.

Drüeke TB, Massy ZA.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):6-8. doi: 10.2215/CJN.12021017. Epub 2017 Dec 5. No abstract available.

PMID:
29208625
5.

[Aluminic intoxication in chronic hemodialysis. A diagnosis rarely evoked nowadays. Clinical case and review of the literature].

Seidowsky A, Dupuis E, Drueke T, Dard S, Massy ZA, Canaud B.

Nephrol Ther. 2017 Nov 22. pii: S1769-7255(17)30553-9. doi: 10.1016/j.nephro.2017.04.002. [Epub ahead of print] French.

PMID:
29174672
6.

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.

Storey BC, Staplin N, Haynes R, Reith C, Emberson J, Herrington WG, Wheeler DC, Walker R, Fellström B, Wanner C, Landray MJ, Baigent C; SHARP Collaborative Group.

Kidney Int. 2017 Nov 14. pii: S0085-2538(17)30725-1. doi: 10.1016/j.kint.2017.09.011. [Epub ahead of print]

7.

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease.

Kaboré J, Metzger M, Helmer C, Berr C, Tzourio C, Drueke TB, Massy ZA, Stengel B.

Kidney Int Rep. 2016 Oct 31;2(2):180-191. doi: 10.1016/j.ekir.2016.10.006. eCollection 2017 Mar.

8.

The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysis.

Fraser SDS, Fenton A, Harris S, Shardlow A, Liabeuf S, Massy ZA, Burmeister A, Hutchison CA, Landray M, Emberson J, Kalra P, Ritchie JP, Cockwell P, Taal MW.

Mayo Clin Proc. 2017 Nov;92(11):1671-1681. doi: 10.1016/j.mayocp.2017.08.021. Epub 2017 Nov 1. Review. Erratum in: Mayo Clin Proc. 2017 Dec;92 (12 ):1866.

PMID:
29101935
9.

Magnesium supplementation: A consideration in dialysis patients.

Apetrii M, Covic A, Massy ZA.

Semin Dial. 2018 Jan;31(1):11-14. doi: 10.1111/sdi.12653. Epub 2017 Oct 23.

PMID:
29063671
10.

Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.

Lenglet A, Liabeuf S, Esper NE, Brisset S, Mansour J, Lemaire-Hurtel AS, Mary A, Brazier M, Kamel S, Mentaverri R, Choukroun G, Fournier A, Massy ZA.

Nephrol Dial Transplant. 2017 Sep 1;32(9):1597. doi: 10.1093/ndt/gfx249. No abstract available.

PMID:
29059402
11.

Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population.

Covic A, Vervloet M, Massy ZA, Torres PU, Goldsmith D, Brandenburg V, Mazzaferro S, Evenepoel P, Bover J, Apetrii M, Cozzolino M.

Lancet Diabetes Endocrinol. 2017 Oct 16. pii: S2213-8587(17)30310-8. doi: 10.1016/S2213-8587(17)30310-8. [Epub ahead of print] Review.

PMID:
29050900
12.

Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study.

Wagner S, Metzger M, Flamant M, Houillier P, Haymann JP, Vrtovsnik F, Thervet E, Boffa JJ, Massy ZA, Stengel B, Rossignol P; NephroTest Study group.

BMC Nephrol. 2017 Oct 6;18(1):308. doi: 10.1186/s12882-017-0723-2. No abstract available.

13.

Bone in CKD: why the ERA EDTA CKD-MBD working group organized a dedicated meeting?

Mazzaferro S, Massy ZA, Vervloet M, Cozzolino M.

J Nephrol. 2017 Oct;30(5):621-622. doi: 10.1007/s40620-017-0436-4. No abstract available.

PMID:
28942478
14.

Validity and reproducibility of a short food frequency questionnaire among patients with chronic kidney disease.

Affret A, Wagner S, El Fatouhi D, Dow C, Correia E, Niravong M, Clavel-Chapelon F, De Chefdebien J, Fouque D, Stengel B; CKD-REIN study investigators, Boutron-Ruault MC, Fagherazzi G.

BMC Nephrol. 2017 Sep 15;18(1):297. doi: 10.1186/s12882-017-0695-2.

15.

Middle-Molecule Uremic Toxins and Outcomes in Chronic Kidney Disease.

Massy ZA, Liabeuf S.

Contrib Nephrol. 2017;191:8-17. doi: 10.1159/000479252. Epub 2017 Sep 14.

16.

Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study.

Wagner S, Metzger M, Flamant M, Houillier P, Haymann JP, Vrtovsnik F, Thervet E, Boffa JJ, Massy ZA, Stengel B, Rossignol P; NephroTest Study group.

BMC Nephrol. 2017 Sep 12;18(1):295. doi: 10.1186/s12882-017-0710-7. Erratum in: BMC Nephrol. 2017 Oct 6;18(1):308.

17.

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study.

Brigant B, Metzinger-Le Meuth V, Massy ZA, McKay N, Liabeuf S, Pelletier M, Sallée M, M'Baya-Moutoula E, Paul P, Drueke TB, Burtey S, Metzinger L.

Clin Kidney J. 2017 Aug;10(4):578. doi: 10.1093/ckj/sfx068. Epub 2017 Jul 9.

18.

Drug-coated balloon angioplasty for dialysis access fistula stenosis.

Boitet A, Massy ZA, Goeau-Brissonniere O, Javerliat I, Coggia M, Coscas R.

Semin Vasc Surg. 2016 Dec;29(4):178-185. doi: 10.1053/j.semvascsurg.2016.08.002. Epub 2016 Aug 11. Review.

PMID:
28779784
19.

Predictors of nonfunctional arteriovenous access at hemodialysis initiation and timing of access creation: A registry-based study.

Alencar de Pinho N, Coscas R, Metzger M, Labeeuw M, Ayav C, Jacquelinet C, Massy ZA, Stengel B.

PLoS One. 2017 Jul 27;12(7):e0181254. doi: 10.1371/journal.pone.0181254. eCollection 2017.

20.

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study.

Brigant B, Metzinger-Le Meuth V, Massy ZA, McKay N, Liabeuf S, Pelletier M, Sallée M, M'Baya-Moutoula E, Paul P, Drueke TB, Burtey S, Metzinger L.

Clin Kidney J. 2017 Feb;10(1):30-37. doi: 10.1093/ckj/sfw060. Epub 2016 Jul 4. Retraction in: Clin Kidney J. 2017 Aug;10 (4):578.

Supplemental Content

Loading ...
Support Center